Adjunctive brexpiprazole (OPC-34712) in patients with major depressive disorder and anxiety symptoms: an exploratory study

被引：0
|
作者：
Davis, Lori [1 ,2 ]
Ota, Ai [3 ]
Perry, Pamela [4 ]
Tsuneyoshi, Kana [3 ]
Weiller, Emmanuelle [5 ]
Baker, Ross [4 ]
机构：
[1] Vet Affairs Med Ctr, Tuscaloosa, AL USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[3] Otsuka Pharmaceut Co Ltd, Tokyo, Japan
[4] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[5] H Lundbeck & Co AS, Valby, Denmark
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS151
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Anxiety Symptoms: An Exploratory Study
    Davis, Lori L.
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 66S - 66S
  • [2] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: An Exploratory Study
    Menard, Francois
    Fava, Maurizio
    Davidsen, Charlotte Kampp
    Baker, Ross A.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 65S - 65S
  • [3] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Sleep Disturbances: An Exploratory Study
    Krystal, Andrew
    Mittoux, Aurelia
    Meisels, Peter
    Baker, Ross
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 64S - 65S
  • [4] Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study
    Baker, R.
    Ota, A.
    Perry, P.
    Tsuneyoshi, K.
    Weiller, E.
    Weisler, R.
    Sheehan, D. V.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S449 - S449
  • [5] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: A Post-Hoc Analysis on Symptoms of Anger
    Menard, Francois
    Davidsen, Charlotte Kampp
    Weiller, Emmanuelle
    Baker, Ross A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S175 - S176
  • [6] Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
    Davis, Lori L.
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross A.
    [J]. BRAIN AND BEHAVIOR, 2016, 6 (10):
  • [7] Efficacy and Safety of Adjunctive Brexpiprazole (OPC-34712) in Major Depressive Disorder: Results: of Two Pivotal Clinical Studies
    Thase, Michael
    Youakim, James
    Skuban, Alexander
    Hobart, Mary
    Zhang, Peter
    Legacy, Susan
    McQuade, Robert
    Nyilas, Margaretta
    Carson, William
    Sanchez, Raymond
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S357 - S357
  • [8] EFFICACY AND SAFETY OF ADJUNCTIVE BREXPIPRAZOLE (OPC-34712) IN MAJOR DEPRESSIVE DISORDER (MDD): A PHASE III, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Thase, M. E.
    Hobart, M.
    Augustine, C.
    Youakim, J.
    Zhang, P.
    Hefting, N.
    McQuade, R. D.
    Carson, W.
    Nyilas, M.
    Sanchez, R.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
  • [9] Effect of adjunctive brexpiprazole (OPC-34712) on depressive symptoms in patients with symptoms of anxious distress: results from post-hoc analyses
    Weiller, E.
    McIntyre, R. S.
    Zhang, P.
    Weiss, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S444 - S445
  • [10] Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
    Eriksson, Hans
    Weiller, Emmanuelle
    Weiss, Catherine
    Zhang, Peter
    Skuban, Aleksandar
    Thase, Michael E.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 102 - 102
12345